Questions? Call 888-624-8373

PAPERBACK + PDF
your price: $70.50
add to cart

PAPERBACK
list:$59.95
Web:$53.96
add to cart

PDF BOOK
your price: $46.00
add to cart

PDF CHAPTERS
your price: $4.50
select

Rights & Permissions

topleft topright

Pathways of Addiction: Opportunities in Drug Abuse Research (1996)
Institute of Medicine (IOM)

Page
297
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Pathways of Addiction: Opportunities in Drug Abuse Research

TABLE C.2 Diagnostic Criteria for Harmful Use and Dependence (ICD-10)

Harmful Use:

A pattern of psychoactive substance use that is causing damage to health. The damage may be physical (as in cases of hepatitis from the self-administration of injected drugs) or mental (e.g. episodes of depressive disorder secondary to heavy consumption of alcohol).

Diagnostic Guidelines: The diagnosis requires that actual damage should have been caused to the mental or physical health of the user.

Harmful patterns of use are often criticized by others and frequently associated with adverse social consequences of various kinds. The fact that a pattern of use or particular substance is disapproved of by another person or by the culture, or may have led to socially negative consequences such as arrest or marital arguments is not in itself evidence of harmful use.

Acute intoxication or ''hangover" is not in itself sufficient evidence of the damage to health required for coding harmful use.

Harmful use should not be diagnosed if dependence syndrome, a psychotic disorder, or another specific form of drug- or alcohol-related disorder is present.

Dependence Syndrome:

Diagnostic Guidelines: A definite diagnosis of dependence should usually only be made if three or more of the following have been experienced or exhibited at some time during the previous year:

(i) A strong desire or sense of compulsion to take the substance.

(ii) Difficulties in controlling substance-taking behavior in terms of its onset, termination, or levels of use.

(iii) A physiological withdrawal state when substance use has ceased or been reduced, as evidenced by: the characteristic withdrawal syndrome for the substance; or use of the same (or closely related) substance with the intention of relieving or avoiding withdrawal symptoms.

(iv) Evidence of tolerance such that increased doses of the substance are required in order to achieve effects originally produced by lower doses. (Clear examples of this are found in alcohol- and opiate-dependent individuals who may take daily doses sufficient to incapacitate or kill nontolerant users.)

(v) Progressive neglect of alternative pleasures or interests because of psychoactive substance use, increased amounts of time necessary to obtain or take the substance or recover from its effects.

(vi) Persisting with substance use despite clear evidence of overtly harmful consequences, such as harm to the liver through excessive drinking, depressive mood states consequent to periods of heavy substance use, or drug-related impairment of

Page
297